Anja Schiel

996 total citations
24 papers, 582 citations indexed

About

Anja Schiel is a scholar working on Economics and Econometrics, Statistics and Probability and Molecular Biology. According to data from OpenAlex, Anja Schiel has authored 24 papers receiving a total of 582 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Economics and Econometrics, 9 papers in Statistics and Probability and 4 papers in Molecular Biology. Recurrent topics in Anja Schiel's work include Health Systems, Economic Evaluations, Quality of Life (14 papers), Statistical Methods in Clinical Trials (9 papers) and Biomedical Ethics and Regulation (3 papers). Anja Schiel is often cited by papers focused on Health Systems, Economic Evaluations, Quality of Life (14 papers), Statistical Methods in Clinical Trials (9 papers) and Biomedical Ethics and Regulation (3 papers). Anja Schiel collaborates with scholars based in Norway, Netherlands and United Kingdom. Anja Schiel's co-authors include Warner S. Simonides, Martin Posch, Onno Bakker, George G. J. M. Kuiper, Ellen Kaptein, Theo J. Visser, H. Craig Morton, Jan G. J. van de Winkel, Olivier Collignon and Henk P.J. Buermans and has published in prestigious journals such as PLoS ONE, The Lancet Oncology and Endocrinology.

In The Last Decade

Anja Schiel

23 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anja Schiel Norway	13	150	125	124	100	99	24	582
Panpan Wang China	9	117 0.8×	42 0.3×	53 0.4×	84 0.8×	242 2.4×	19	663
Jacqueline Corrigan‐Curay United States	9	135 0.9×	106 0.8×	148 1.2×	28 0.3×	17 0.2×	13	616
Huei‐Ting Tsai United States	16	76 0.5×	51 0.4×	27 0.2×	56 0.6×	56 0.6×	27	589
L. Esserman United States	7	114 0.8×	207 1.7×	106 0.9×	23 0.2×	11 0.1×	39	703
Josephina G. Kuiper Netherlands	13	63 0.4×	19 0.2×	54 0.4×	71 0.7×	154 1.6×	37	640
Cathy Anne Pinto United States	11	22 0.1×	35 0.3×	159 1.3×	63 0.6×	86 0.9×	29	509
Issa Alesh United States	9	62 0.4×	14 0.1×	128 1.0×	367 3.7×	233 2.4×	21	982
Sarah Goring United States	15	104 0.7×	67 0.5×	93 0.8×	7 0.1×	114 1.2×	37	613
Hayan Jouni United States	16	194 1.3×	15 0.1×	49 0.4×	285 2.9×	41 0.4×	48	953
Ming‐yi Hu United States	15	511 3.4×	39 0.3×	38 0.3×	88 0.9×	46 0.5×	22	1.2k

Countries citing papers authored by Anja Schiel

Since Specialization

Citations

This map shows the geographic impact of Anja Schiel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anja Schiel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anja Schiel more than expected).

Fields of papers citing papers by Anja Schiel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anja Schiel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anja Schiel. The network helps show where Anja Schiel may publish in the future.

Co-authorship network of co-authors of Anja Schiel

This figure shows the co-authorship network connecting the top 25 collaborators of Anja Schiel. A scholar is included among the top collaborators of Anja Schiel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anja Schiel. Anja Schiel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Pignatti, Francesco, Peter G. M. Mol, Chantal Quinten, et al.. (2025). Use of patient-reported outcomes to inform symptom and functional outcomes in cancer drug regulatory decisions: challenges and future directions. The Lancet Oncology. 26(6). 664–666.

Gamper, Eva‐Maria, Madeleine King, Anja Schiel, et al.. (2025). Shifting perspectives: a reflection on cancer-specific quality-of-life metrics in cancer care economics. The Lancet Oncology. 26(5). 545–547. 1 indexed citations

Mol, Peter G. M., Walter Van Dyck, Anja Schiel, et al.. (2024). Navigating the path towards successful implementation of the EU HTA Regulation: key takeaways from the 2023 Spring Convention of the European Access Academy. Health Research Policy and Systems. 22(1). 74–74. 7 indexed citations

Ruof, Jörg, Peter G. M. Mol, Walter Van Dyck, et al.. (2024). Evaluating progress towards implementation of the European HTA Regulation: Insights generated from the European Access Academy's multi-stakeholder survey. Health Policy and Technology. 13(5). 100930–100930. 4 indexed citations

Tourneau, Christophe Le, Fabrice André, Åslaug Helland, et al.. (2023). Modified study designs to expand treatment options in personalised oncology: a multistakeholder view. European Journal of Cancer. 194. 113278–113278. 3 indexed citations

Dunger‐Baldauf, Cornelia, et al.. (2023). Generating the Right Evidence at the Right Time: Principles of a New Class of Flexible Augmented Clinical Trial Designs. Clinical Pharmacology & Therapeutics. 113(5). 1132–1138. 3 indexed citations

Capkun, Gorana, Cláudia Furtado, Páll Jónsson, et al.. (2022). Can we use existing guidance to support the development of robust real-world evidence for health technology assessment/payer decision-making?. International Journal of Technology Assessment in Health Care. 38(1). e79–e79. 14 indexed citations

Gould, A. Lawrence, R. Keith Campbell, John W. Loewy, et al.. (2022). A framework for assessing the impact of accelerated approval. PLoS ONE. 17(6). e0265712–e0265712. 4 indexed citations

Collignon, Olivier, Anja Schiel, Carl‐Fredrik Burman, et al.. (2022). Estimands and Complex Innovative Designs. Clinical Pharmacology & Therapeutics. 112(6). 1183–1190. 12 indexed citations

10.

Bakker, Elisabeth, Peter G. M. Mol, J.M. Valente Nabais, et al.. (2021). Perspectives on a Way Forward to Implementation of Precision Medicine in Patients With Diabetic Kidney Disease; Results of a Stakeholder Consensus-Building Meeting. Frontiers in Pharmacology. 12. 662642–662642. 1 indexed citations

11.

Burger, Hans Ulrich, Christoph Gerlinger, Chris Harbron, et al.. (2021). The use of external controls: To what extent can it currently be recommended?. Pharmaceutical Statistics. 20(6). 1002–1016. 47 indexed citations

12.

Tavridou, Anna, et al.. (2020). Towards a better use of scientific advice for developers of advanced therapies. British Journal of Clinical Pharmacology. 87(6). 2459–2464. 7 indexed citations

13.

Collignon, Olivier, Christian Gärtner, Anna‐Bettina Haidich, et al.. (2020). Current Statistical Considerations and Regulatory Perspectives on the Planning of Confirmatory Basket, Umbrella, and Platform Trials. Clinical Pharmacology & Therapeutics. 107(5). 1059–1067. 59 indexed citations

14.

Tenhunen, Olli, et al.. (2020). Single‐Arm Clinical Trials as Pivotal Evidence for Cancer Drug Approval: A Retrospective Cohort Study of Centralized European Marketing Authorizations Between 2010 and 2019. Clinical Pharmacology & Therapeutics. 108(3). 653–660. 28 indexed citations

15.

Bouvy, Jacoline C., Páll Jónsson, Antonella Santuccione Chadha, et al.. (2018). Regulatory and Health Technology Assessment Considerations for Disease-Modifying Drugs in Alzheimer’s Disease. CNS Drugs. 32(12). 1085–1090. 4 indexed citations

16.

Lim, Robyn, John Ferguson, Marilyn Metcalf, et al.. (2018). Recognizing that Evidence is Made, not Born. Clinical Pharmacology & Therapeutics. 105(4). 844–856. 2 indexed citations

17.

Alkemade, Fanneke E., Adriana C. Gittenberger–de Groot, Anja Schiel, et al.. (2007). Intrauterine Exposure to Maternal Atherosclerotic Risk Factors Increases the Susceptibility to Atherosclerosis in Adult Life. Arteriosclerosis Thrombosis and Vascular Biology. 27(10). 2228–2235. 52 indexed citations

18.

Schiel, Anja, George G. J. M. Kuiper, Ellen Kaptein, et al.. (2002). Induction of Thyroid Hormone-Degrading Deiodinase in Cardiac Hypertrophy and Failure. Endocrinology. 143(7). 2812–2815. 114 indexed citations

19.

Morton, H. Craig, et al.. (1996). Alternatively spliced forms of the human myeloid Fc&; receptor (CD89) in neutrophils. Immunogenetics. 43(4). 246–247. 26 indexed citations

20.

Morton, H. Craig, et al.. (1996). Alternatively spliced forms of the human myeloid Fcα receptor (CD89) in neutrophils. Immunogenetics. 43(4). 246–247. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact